التفاصيل البيبلوغرافية
العنوان: |
Six month immunogenicity of COVID-19 mRNA-BNT162b2 vaccine in actively treated cancer patients: updated results of the Vax-On study |
المؤلفون: |
F. Nelli, A. Fabbri, A. Onorato, D. Giannarelli, M.A. Silvestri, G. Pessina, J.R. Giron Berrios, A. Virtuoso, E. Marrucci, M. Schirripa, M. Mazzotta, V. Panichi, P. Cercola, C. Signorelli, M.G. Chilelli, F. Primi, E.M. Ruggeri |
المصدر: |
Annals of Oncology |
سنة النشر: |
2021 |
مصطلحات موضوعية: |
SARS-CoV-2, COVID-19, Hematology, tozinameran, immunogenicity, six-months follow-up, Oncology, Neoplasms, Humans, cancer, RNA, Messenger, anticancer therapy, Letter to the Editor, BNT162 Vaccine |
تدمد: |
1569-8041 |
URL الوصول: |
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae882939175e67456906e02dafa64bf7 https://pubmed.ncbi.nlm.nih.gov/34896598 |
حقوق: |
OPEN |
رقم الأكسشن: |
edsair.doi.dedup.....ae882939175e67456906e02dafa64bf7 |
قاعدة البيانات: |
OpenAIRE |